RGC
Roberts, Glore & Co Portfolio holdings
AUM
$342M
This Quarter Return
-2.49%
1 Year Return
+15.34%
3 Year Return
+56.21%
5 Year Return
+102.72%
10 Year Return
+238.78%
AUM
$303M
AUM Growth
+$303M
(-3.2%)
Cap. Flow
+$159K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
36.91%
Holding
202
New
2
Increased
41
Reduced
94
Closed
4
Top Buys
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$708K |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$557K |
| 3 |
Apple
AAPL
|
$325K |
| 4 |
iShares TIPS Bond ETF
TIP
|
$243K |
| 5 |
WIW
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
|
$233K |
Sector Composition
| 1 | Healthcare | 19.16% |
| 2 | Technology | 16.55% |
| 3 | Financials | 11.87% |
| 4 | Industrials | 8.7% |
| 5 | Communication Services | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sprott Physical Gold and Silver Trust
CEF
$6.42B
| $2.59M | 0.86% |
149,621
+600
| +0.4% | +$10.4K |
|
27
Walmart
WMT
$781B
| $2.51M | 0.83% |
15,691
-105
| -0.7% | -$16.8K |
|
28
Norfolk Southern
NSC
$62.4B
| $2.4M | 0.79% |
12,176
-250
| -2% | -$49.2K |
|
29
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.2B
| $2.36M | 0.78% |
31,401
+4,402
| +16% | +$331K |
|
|
ATRI
30
DELISTED
Atrion Corp
ATRI
| $2.3M | 0.76% |
5,575
-55
| -1% | -$22.7K |
|
31
Procter & Gamble
PG
$370B
| $2.29M | 0.76% |
15,732
-185
| -1% | -$27K |
|
32
Amgen
AMGN
$154B
| $2.28M | 0.75% |
8,495
-25
| -0.3% | -$6.72K |
|
33
Linde
LIN
$222B
| $2.28M | 0.75% |
6,116
-395
| -6% | -$147K |
|
34
Becton Dickinson
BDX
$53.9B
| $2.22M | 0.73% |
8,592
| – | – |
|
35
Arista Networks
ANET
$171B
| $2.22M | 0.73% |
12,075
-850
| -7% | -$156K |
|
36
RTX Corp
RTX
$212B
| $2.07M | 0.68% |
28,696
+1,996
| +7% | +$144K |
|
37
Vanguard Small-Cap Value ETF
VBR
$31.2B
| $2.06M | 0.68% |
12,945
+37
| +0.3% | +$5.9K |
|
38
Centene
CNC
$14.5B
| $2.04M | 0.68% |
29,659
+1,190
| +4% | +$82K |
|
39
Vanguard Mega Cap Value ETF
MGV
$9.83B
| $2.03M | 0.67% |
20,055
-214
| -1% | -$21.7K |
|
40
CVS Health
CVS
$94B
| $1.98M | 0.65% |
28,391
+1,745
| +7% | +$122K |
|
41
Union Pacific
UNP
$132B
| $1.93M | 0.64% |
9,490
-75
| -0.8% | -$15.3K |
|
42
Vanguard Dividend Appreciation ETF
VIG
$95B
| $1.91M | 0.63% |
12,323
-61
| -0.5% | -$9.48K |
|
43
Quest Diagnostics
DGX
$20B
| $1.89M | 0.63% |
15,539
| – | – |
|
44
Vertex Pharmaceuticals
VRTX
$103B
| $1.79M | 0.59% |
5,138
-14
| -0.3% | -$4.87K |
|
45
Bio-Techne
TECH
$8.31B
| $1.78M | 0.59% |
26,108
-18
| -0.1% | -$1.23K |
|
46
Invesco Taxable Municipal Bond ETF
BAB
$897M
| $1.78M | 0.59% |
70,201
+7,700
| +12% | +$195K |
|
47
Novartis
NVS
$245B
| $1.7M | 0.56% |
16,676
-250
| -1% | -$25.5K |
|
48
M&T Bank
MTB
$31.1B
| $1.63M | 0.54% |
12,856
-158
| -1% | -$20K |
|
49
Meta Platforms (Facebook)
META
$1.85T
| $1.6M | 0.53% |
5,338
-649
| -11% | -$195K |
|
50
CME Group
CME
$95.6B
| $1.6M | 0.53% |
8,001
| – | – |
|